CN102302719B - Medicament for treating tumor - Google Patents
Medicament for treating tumor Download PDFInfo
- Publication number
- CN102302719B CN102302719B CN2011102519461A CN201110251946A CN102302719B CN 102302719 B CN102302719 B CN 102302719B CN 2011102519461 A CN2011102519461 A CN 2011102519461A CN 201110251946 A CN201110251946 A CN 201110251946A CN 102302719 B CN102302719 B CN 102302719B
- Authority
- CN
- China
- Prior art keywords
- medicament
- tumor
- prepared
- treating tumor
- curative effects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating tumor. The medicament is prepared from the following Chinese herbal medicines: common lophatherum herb, Paris polyphylla, largehead atractylodes, atractylodes lancea, pale butterflybush flower, rhubarb, platycodon grandiflorum, dwarf lilyturf tuber, angelica sinensis, scirpus fluviatilis, Chinese magnoliavine fruit and barbed skullcap herb. The medicament is prepared from pure Chinese medicines, keeps the characteristics of small toxicity and good curative effects of natural medicaments, is exact in curative effects, and can effectively treat tumor.
Description
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of medicament of treating tumor.
Background technology
Tumor (Tumor) be body under various carcinogenic factor effects, some cells of local organization lose the normal regulation to its growth on gene level, cause its clonal abnormality hypertrophy and the neoplasm that forms.It is generally acknowledged that tumor cell is a monoclonicity, promptly all oncocytes in tumor all are offsprings of the cell of a sudden change.Generally tumor is divided into optimum and pernicious two big types.All malignant tumor are generically and collectively referred to as cancer (cancer).
Many clinically at present employing chemicalses are treated, but often the injury for the patient is bigger for chemotherapeutics.
Summary of the invention
The purpose of this invention is to provide a kind of medicament of treating tumor.
In order to realize the object of the invention, the present invention provides a kind of medicament of treating tumor, and it is processed by following bulk drugs by weight:
Preferably, it is processed by following bulk drugs by weight:
Preferably, medicament of the present invention is tablet, dispersible tablet, decoction or capsule.
Medicament of the present invention is prepared with pure Chinese medicine, keeps little, the eutherapeutic characteristic of natural drug toxicity, and curative effect is clear and definite, can treat tumor effectively.
The specific embodiment
Below description through the specific embodiment the present invention is described further; But this is not to be limitation of the present invention; Those skilled in the art are according to basic thought of the present invention; Can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within scope of the present invention.
The preparation of embodiment 1 decoction of the present invention
Get Herba Lophatheri 100 gram, Rhizoma Paridis 100 grams, the Rhizoma Atractylodis Macrocephalae 30 grams, Rhizoma Atractylodis 30 grams, Flos Buddlejae 100 grams, Radix Et Rhizoma Rhei 50 grams, Radix Platycodonis 50 grams, Radix Ophiopogonis 100 gram, Radix Angelicae Sinensis 50 grams, triangular 50 grams, Fructus Schisandrae Chinensis 100 grams, Herba Scutellariae Barbatae 100 grams; Place 800 ml waters; 90 ℃ of following reflux 3 hours; Filter, obtain filtering residue and filtrating.Said filtrating is concentrated into 300 milliliters, promptly gets.
Experimental example
Physical data
50 routine patients all confirm through B ultrasonic, CT or MRI imaging examination, all do alpha-fetoprotein determination, are diagnosed as primary hepatocarcinoma.Wherein, male's 25 examples, women's 25 examples, age 33-71 year, average 50.1 years old, wherein, II phase patient 20 examples, III phase patient 30 examples.
Receive people's standard
(1) with reference to the primary hepatocarcinoma diagnostic criteria of hepatocarcinoma Professional Committee of Chinese Anti-Cancer Association; (2) Chinese medical discrimination belong to syndrome of blood stasis (Ministry of Health of the People's Republic of China. new Chinese medicine clinical research guideline [S]. the 1st volume, 1993.170-731); (3) physical situation Karnofsky scoring is more than 60 minutes.
Take the decoction of preparation among the embodiment 1, three times on the one, each 50 milliliters.Treatment is 3 months continuously.
The therapeutic evaluation standard
The objective therapeutic evaluation standard of formulating according to WHO of solid tumor (the Sun Yan chief editor. medical oncology. Beijing: the People's Health Publisher, 2001.994-996) formulate following evaluation criteria: produce effects: treatment rear section transference cure, the Karnofsky integration reduces >=2/3; Effectively: treatment back symptom takes a turn for the better, and the Karnofsky integration reduces >=1/3, but＜2/3; Invalid: treatment back symptom does not have obvious improvement, the constant or integration reduction＜1/3 of Karnofsky integration.Karnofsky scoring: according to " situation score standard in the body " (the Sun Yan chief editor. medical oncology. Beijing: the People's Health Publisher, 2001.994-996) add up.
On inspection, whole 50 routine patients all meet the standard of produce effects after treating after treatment.
Untoward reaction: untoward reaction does not appear in 50 routine patients in therapeutic process.
Claims (2)
1. plant the medicament of treatment tumor, it is characterized in that it is processed by following bulk drugs by weight:
2. the medicament of treatment tumor according to claim 1 is characterized in that, said medicament is tablet, decoction or capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102519461A CN102302719B (en) | 2011-08-30 | 2011-08-30 | Medicament for treating tumor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102519461A CN102302719B (en) | 2011-08-30 | 2011-08-30 | Medicament for treating tumor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102302719A CN102302719A (en) | 2012-01-04 |
| CN102302719B true CN102302719B (en) | 2012-11-28 |
Family
ID=45376701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011102519461A Expired - Fee Related CN102302719B (en) | 2011-08-30 | 2011-08-30 | Medicament for treating tumor |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102302719B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106063815A (en) * | 2014-04-18 | 2016-11-02 | 温先敏 | Flos Buddlejae and extract thereof treat the application of the medicine of vascular lesion as preparation |
| CN106389546A (en) * | 2016-10-18 | 2017-02-15 | 漯河医学高等专科学校 | Traditional Chinese medicine for postoperative treatment of colorectal cancer and preparation method of traditional Chinese medicine |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1437977A (en) * | 2003-01-13 | 2003-08-27 | 许新琳 | Medicine for treating lung cancer |
-
2011
- 2011-08-30 CN CN2011102519461A patent/CN102302719B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102302719A (en) | 2012-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103041312B (en) | Traditional Chinese medicine composition with antineoplastic effect and preparation method and application thereof | |
| CN101239112B (en) | Chinese medicinal composition for regulating blood fat and preparation thereof | |
| CN101234164B (en) | Pharmaceutical combination for improving skin oil-water balance and acne symptom and preparation thereof | |
| CN102008650A (en) | Compound traditional Chinese medicine preparation for treating tumors and preparation method thereof | |
| CN102302719B (en) | Medicament for treating tumor | |
| CN101804189B (en) | Drug for treating primary dysmenorrhea | |
| CN102309708B (en) | Drug for treating tumor | |
| CN101991807A (en) | Chinese herbal compound for treating liver cancer | |
| CN101623455B (en) | Medicine for treating prostate hyperplasia | |
| CN101664533A (en) | Chinese medicament for treating acute and chronic mammary hyperplasia and preparation method | |
| CN104888137B (en) | A kind of pharmaceutical preparation for treating polycystic ovary syndrome | |
| CN101411770B (en) | Medicament for treating blood stasis accumulation type multiple sclerosis symptoms | |
| CN103705846A (en) | Traditional Chinese medicine preparation for treating ovarian cyst | |
| CN103223149A (en) | Chinese herb medicine composition for treating lung cancer | |
| CN103638149B (en) | Traditional Chinese medicine composition for treating rectal cancer | |
| CN106309749A (en) | Traditional Chinese medicine for treating cervical cancer | |
| CN102293916B (en) | Medicine for treating orthodontic gingivitis | |
| CN102225155B (en) | Medicament composition for treating pulmonary fibrosis | |
| CN101411810B (en) | Medicament for treating multiple sclerosis symptoms | |
| CN104888149A (en) | Drug for treating cervical cancer and preparation method for drug | |
| CN104352669B (en) | A kind of application of Chinese medicine in weak sperm disease is treated | |
| CN103610932A (en) | Medicament for treating urinary calculus | |
| CN102836315A (en) | Chinese medicinal composition for preventing and conditioning prognosis tumors and preparation method thereof | |
| CN102526385A (en) | Medicament for treating climacteric syndrome | |
| CN102836354A (en) | Medicament for treating depression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121128 Termination date: 20130830 |